Baby Safety / Compounds / Perfluorooctane sulfonic acid (PFOS)

Is Perfluorooctane sulfonic acid (PFOS) safe for babies and kids?

Elevated risk for kids

Infants accumulate Perfluorooctane sulfonic acid (PFOS) through breast milk (bioconcentration), placental transfer, and dust ingestion. Persistent pollutants concentrate in fatty tissues with extended half-lives in developing organisms.

What is perfluorooctane sulfonic acid (pfos)?

The IUPAC name is 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonic acid.

Also known as: 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonic acid, Perfluorooctanesulfonic acid, PFOS, Perfluorooctane sulfonic acid.

IUPAC name: 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonic acid
CAS number: 1763-23-1
Molecular formula: C8HF17O3S
Molecular weight: 500.13 g/mol
SMILES: C(C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F
PubChem CID: 74483

Risk for babies

Elevated risk

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

High risk

PFOS crosses the placenta and concentrates in cord blood — fetal PFOS concentrations in some cohorts are comparable to maternal levels, confirming substantial fetal exposure. PFOS has been detected in amniotic fluid and breast milk, creating continuous fetal and neonatal exposure pathways. Epidemiological evidence for reproductive and developmental effects is substantial: prenatal PFOS exposure has been associated with reduced fetal growth (lower birth weight, shorter birth length), preeclampsia, reduced sperm count in male offspring (Danish National Birth Cohort), and delayed puberty in girls. PFOS impairs thyroid function in pregnant women and their fetuses — thyroid hormones are critical for fetal brain development and are tightly regulated during pregnancy; PFOS-induced hypothyroxinemia has developmental neurological implications. The Pregnancy Risk Assessment Monitoring System (PRAMS) and NHANES pregnancy sub-cohorts show measurable PFOS in virtually all pregnant women sampled in the US. Given PFOS's multi-year biological half-life, body burden reduction before pregnancy requires years of reduced exposure — not achievable through typical pre-conception behavioral modifications. Reduction of PFOS-contaminated drinking water exposure is the highest-priority mitigation strategy for pregnant women in affected communities.

Regulatory consensus

6 regulatory and scientific bodies have classified Perfluorooctane sulfonic acid (PFOS). The classifications differ — that's the data.

Agency	Year	Classification	Notes
IARC	2023	Group 2A (probably carcinogenic to humans)	IARC Monographs Volume 135 (2023). PFOS classified Group 2A based on sufficient evidence in animals (thyroid and kidney tumors in rats) and limited evidence in humans (associations with kidney and testicular cancer in occupationally exposed cohorts and general population studies). PFOS and PFOA were jointly evaluated; both classified 2A. PFOS is an anionically stable perfluoroalkyl sulfonate — essentially non-metabolizable in mammalian systems, conferring extreme biological persistence. Stockholm Convention Annex B (2009, restricted): production and use restricted globally except for specific exemptions (firefighting foam, semiconductor manufacturing). US EPA PFAS National Primary Drinking Water Regulation (2024) set Maximum Contaminant Level (MCL) for PFOS at 4 parts per trillion (ppt) — same as PFOA — reflecting the Agency's determination that no safe level can be confidently established.
US EPA	2024	Likely carcinogenic to humans (PFAS class finding)	US EPA 2024 PFAS NPDWR: Established MCL of 4 ppt for PFOS individually; 10 ppt as a hazard index for mixtures including PFOS. The 2024 rule reflects EPA's determination that PFOS poses cancer risk (kidney cancer as the primary endpoint) at concentrations detectable in drinking water supplies. EPA's PFAS Strategic Roadmap (2021–2024) designated PFOS as a priority substance for regulatory action across environmental media. PFOS is also regulated under TSCA (Section 6 rulemaking) and RCRA (as a hazardous constituent in AFFF disposal). PFOS contamination from historical use of aqueous film-forming foam (AFFF) at military installations and airports is the primary point-source contamination scenario in the US, affecting groundwater supplies for millions of Americans.
EPA CTX / Genetox	—	Genotoxicity: positive (Ames: negative, 1 positive / 2 negative reports)
EPA CTX / Genetox	—	Genotoxicity: positive (Ames: negative, 1 positive / 2 negative reports)
EPA CTX / Skin-Eye	—	Eye Irritation: Category 2B (score: moderate)
EPA CTX / Skin-Eye	—	Skin Irritation: Not classified (score: low)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter perfluorooctane sulfonic acid (pfos)

Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Perfluorooctane sulfonic acid (PFOS):

Silicone-based water repellents (for textiles)
Trade-offs: Lower durability. May need more frequent reapplication.

Relative cost: 1.5-3×
Wax-based treatments (paraffin/plant wax)
Trade-offs: Poor performance in heavy rain or sustained wet conditions

Relative cost: 1.2-2×

Frequently asked questions

Is perfluorooctane sulfonic acid (pfos) safe for kids?

What products contain perfluorooctane sulfonic acid (pfos)?

Perfluorooctane sulfonic acid (PFOS) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to perfluorooctane sulfonic acid (pfos)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about perfluorooctane sulfonic acid (pfos)?

Perfluorooctane sulfonic acid (PFOS) has been classified by 6 agencies including IARC, US EPA, EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Perfluorooctane sulfonic acid (PFOS) in the baby app

Look up products containing perfluorooctane sulfonic acid (pfos), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (3)

IARC Monographs Volume 135: Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonic Acid (PFOS) — Group 2A Evaluation (Probably Carcinogenic to Humans) (2023) — regulatory
US EPA: National Primary Drinking Water Regulation for PFAS — Maximum Contaminant Level Goals and MCLs for PFOA, PFOS, and Four Other PFAS (Final Rule) (2024) — regulatory
US EPA: PFAS Strategic Roadmap — EPA's Commitments to Action 2021–2024 (PFOS/PFOA Priority Designation and Regulatory Framework) (2021) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →